Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Moberg Pharma partner Menarini Asia-Pacific introduces Kerasal Nail in china Moberg Pharma has announced that its partner, Menarini Asia-Pacific, has initiated the launch of Kerasal Nail in China. TV commercials and other advertising started this week in certain parts of southern China.
Production & Manufacturing > OTC > News
Sunovion reports positive results for Latuda in first placebo-controlled trial in MDD patients Sunovion Pharmaceuticals (Sunovion) announced results from the first placebo-controlled study in adults with major depressive disorder (MDD) who presented with a limited number of associated manic symptoms (mixed features).
Production & Manufacturing > OTC > News Inergetics, Muscle Maker Grill introduce new booster supplements product line Inergetics, a world-class developer of nutritional and consumer health products, announced the launch of a new product line of booster supplements at Muscle Maker Grill locations across the US.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Actavis introduces Namzaric in US to treat moderate to severe Alzheimer's disease
By PBR Staff Writer
Irish over-the-counter (OTC) firm Actavis has launched Namzaric (memantine hydrochloride extended-release and donepezil hydrochloride) in the US to treat moderate to severe Alzheimer's disease (AD).
Production & Manufacturing > OTC > News
Perrigo to promote Paragon BioTeck's ilast products in US
By PBR Staff Writer
US-based Paragon BioTeck has entered into a multi-year agreement with Irish healthcare supplier Perrigo Company to promote the ilast range of products for eyelid hygiene in the US.
Production & Manufacturing > OTC > News
Axxess Pharma's Tapout products now available in 300 plus fitness centers across North America
By PBR Staff Writer
Canada-based Axxess Pharma through its subsidiary AllStar Health Brands USA has signed a contract with AVT, a North American builder and provider of vending machines.
Production & Manufacturing > OTC > News
Perrigo takes over Mexican operations of Patheon for $34m
By PBR Staff Writer
Irish over-the-counter (OTC) firm Perrigo has acquired the Mexican operations of US-based contract pharmaceutical services company Patheon for $34m.
Production & Manufacturing > OTC > News
SeabuckWonders unveils new Hair, Skin & Nails supplement in US
By PBR Staff Writer
US-based SeabuckWonders has launched its new Ultimate Hair, Skin & Nails supplement, which is the only product to feature both Biotin and Sea Buckthorn Oil with rare Omega-7 for US consumers.
Production & Manufacturing > OTC > News
Horizon Pharma enters into settlement and license agreement with Perrigo for Pennsaid 2% patent litigation
Horizon Pharma, a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced that its affiliates have entered into a settlement and license agreement with Perrigo Company and its subsidiary Paddock Laboratories, collectively (Perrigo), to resolve pending patent litigation involving Pennsaid (diclofenac sodium topical solution) 2% w/w (Pennsaid 2%).
Production & Manufacturing > OTC > News
Actavis to re-launch generic pulmicort Respules after favorable appeals court ruling
Actavis has announced that it will immediately re-launch its generic version of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) 0.25 and 0.5mg vials following a decision from the United States Court of Appeals for the Federal Circuit to uphold a lower court's ruling that United States Patent No. 7,524,834 is invalid.
Production & Manufacturing > OTC > News
Lipocine completes Phase III trial of oral testosterone LPCN 1021
Lipocine(LPCN), a specialty pharmaceutical company, has announced the completion of the last patient visit in the safety assessment portion of its Study of Oral Androgen Replacement (SOAR) pivotal Phase III clinical study evaluating efficacy and safety of LPCN 1021, an Oral Testosterone product, in hypogonadal men with low testosterone (Low T).
Production & Manufacturing > OTC > News
Nutra Pharma's OTC drug Nyloxin gets acceptance from CPAM
Nutra Pharma, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, has received notification of the acceptance of Nyloxin by the China International Exchange and Promotive Association for Medical and Healthcare (CPAM).
Production & Manufacturing > OTC > News
Irish OTC firm Perrigo rejects Mylan's raised bid
By PBR Staff Writer
Irish over-the-counter (OTC) firm Perrigo has rejected the revised unsolicited offer from Mylan to acquire all of the outstanding shares of Perrigo for $75 per share in cash and 2.3 Mylan shares for each Perrigo share.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests